Matinas BioPharma Holdings (MTNB) Preferred Shares (2016 - 2021)

Matinas BioPharma Holdings (MTNB) has 6 years of Preferred Shares data on file, last reported at $3.7 million in Q1 2021.

• Preferred Shares for Q1 2021 came in at $3.7 million, down 7.34% year-over-year; the trailing twelve-month figure through Mar 2021 was $3.7 million (down 7.34% YoY), and the FY2020 annual result was $3.8 million, down 4.72% from the prior year.
• Preferred Shares eased to $3.7 million in Q1 2021 per MTNB's latest filing, from $3.8 million in the prior quarter.
• Over five years, Preferred Shares peaked at $6.9 million in Q2 2018 and troughed at $3.7 million in Q1 2021.
• A 5-year average of $5.0 million and a median of $5.6 million in 2019 frame the typical range for Preferred Shares.
• The sharpest annual moves came in 2018 and 2019: Preferred Shares gained 19.8% in 2018, then sank 34.03% in 2019.
• A 5-year view of Preferred Shares shows it stood at $5.7 million in 2017, then decreased by 26.59% to $4.2 million in 2018, then retreated by 5.02% to $4.0 million in 2019, then retreated by 4.72% to $3.8 million in 2020, then declined by 3.28% to $3.7 million in 2021.
• Business Quant data shows MTNB's Preferred Shares at $3.7 million in Q1 2021, $3.8 million in Q4 2020, and $4.0 million in Q3 2020.